TIDM0Y7T TIDM0QCV 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 
---------------------------------------------  ------------------------------- 
Company dealt in                               Allergan plc 
---------------------------------------------  ------------------------------- 
Class of relevant security to which            US$0.0001 ordinary shares 
 the dealings being disclosed relate (Note 2) 
---------------------------------------------  ------------------------------- 
Date of dealing                                08(th) May 2020 
---------------------------------------------  ------------------------------- 
 
 
 
   2. INTERESTS AND SHORT POSITIONS 
 
   (a) Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 3) 
 
 
 
 
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                14,065,332  4.27294% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  14,065,332  4.27294% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                                88                   193.03 
--------------  -----------------------------  ----------------------- 
   Purchase                            28,565                   193.02 
--------------  -----------------------------  ----------------------- 
   Purchase                               511                   193.02 
--------------  -----------------------------  ----------------------- 
   Purchase                                46                   193.02 
--------------  -----------------------------  ----------------------- 
   Purchase                                50                   193.02 
--------------  -----------------------------  ----------------------- 
     Sale                              14,956                   193.02 
--------------  -----------------------------  ----------------------- 
     Sale                               8,800                   193.02 
--------------  -----------------------------  ----------------------- 
     Sale                                 700                   193.02 
--------------  -----------------------------  ----------------------- 
     Sale                               1,900                   193.02 
--------------  -----------------------------  ----------------------- 
     Sale                               1,800                   193.02 
--------------  -----------------------------  ----------------------- 
     Sale                                 200                   193.02 
--------------  -----------------------------  ----------------------- 
     Sale                              11,050                   193.02 
--------------  -----------------------------  ----------------------- 
     Sale                               5,400                   193.02 
--------------  -----------------------------  ----------------------- 
     Sale                                 800                   192.75 
--------------  -----------------------------  ----------------------- 
 
 
 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                    NO 
-------------------------------------------------------  --------------- 
Date of disclosure                                       11(th) May 2020 
-------------------------------------------------------  --------------- 
Contact name                                              Lionel Colaco 
-------------------------------------------------------  --------------- 
Telephone number                                            020 33956098 
-------------------------------------------------------  --------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  --------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  ---------------

(END) Dow Jones Newswires

May 11, 2020 10:12 ET (14:12 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Abbvie (LSE:0QCV)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Abbvie Charts.
Abbvie (LSE:0QCV)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Abbvie Charts.